The WHO has classed this outbreak as “extraordinary” due to the lack of therapeutic options and epidemiological trends.
The wider US HHS is going through a leadership upheaval, as Republicans aim to keep voters on side amid the looming midterm elections.
The FDA has approved Daiichi Sankyo and AstraZeneca’s Enhertu for two new indications in HER2-positive early breast cancer.
Boehringer Ingelheim has received Japan’s MHLW approval for Jascayd (nerandomilast) to treat adults with IPF and PPF.
ITALVACUUM will participate in EXPOQUIMIA 2026, taking place in Barcelona from 2 to 5 June, where the company will present its vacuum drying technologies developed for pharmaceutical and ...
Ovarian cancer research is entering a pivotal era characterized by increasing complexity for large, global studies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results